Patents by Inventor Stephane Delbecq

Stephane Delbecq has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF PARASITIC DISEASES AND METHOD OF PRODUCTION OF THEREOF
    Publication number: 20190040004
    Abstract: Disclosed are new compounds for treating, preventing or inhibiting a parasitic disease, preferably toxoplasmosis in a subject, the method for preparing thereof.
    Type: Application
    Filed: October 9, 2018
    Publication date: February 7, 2019
    Inventors: Denis SERENO, Gilles LABESSE, Jean-Francois Alexandre GUICHOU, Corinne LOEUILLET, Deborah Isabelle GARCIA, Stephane DELBECQ
  • N-hydroxybenzamides as HDAC inhibitors for the treatment of parasitic diseases
    Patent number: 10106493
    Abstract: Compounds of formula wherein n is 0, 1 or 2; X is and Ar is a benzyl substituted at the meta position by a C1 to C8 alkoxy group, or a pharmaceutically acceptable salt thereof, for treating, preventing or inhibiting a parasitic disease, such as toxoplasmosis, in a subject are provided. Methods for preparing the compounds are also presented.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: October 23, 2018
    Assignees: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (I.R.D.), UNIVERSITE DE MONTPELLIER, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Denis Sereno, Gilles Labesse, Jean-Francois Alexandre Guichou, Corinne Loeuillet, Deborah Isabelle Garcia, Stephane Delbecq
  • NEW COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF PARASITIC DISEASES AND METHOD OF PRODUCTION OF THEREOF
    Publication number: 20160168084
    Abstract: Disclosed are new compounds for treating, preventing or inhibiting a parasitic disease, preferably toxoplasmosis in a subject, the method for preparing thereof.
    Type: Application
    Filed: July 17, 2014
    Publication date: June 16, 2016
    Inventors: Denis SERENO, Gilles LABESSE, Jean-Francois Alexandre GUICHOU, Corinne LOEUILLET, Deborah Isabelle GARCIA, Stephane DELBECQ
  • Immunogenic composition
    Publication number: 20060051365
    Abstract: The present invention provides an immunogenic composition comprising a fusion protein and a saponin adjuvant. The fusion protein comprises a heterologous hydrophobic peptide that is fused to the N-terminus and/or to the C-terminus of a core polypeptide. The core polypeptide comprises at least one protective epitope. The saponin adjuvant in this composition is present in a free form. Also provided are vaccines comprising the immunogenic composition and optionally an additional immunoactive component. Methods for the preparation of such vaccines, and use of the immunogenic composition for the manufacture of a vaccine are provided as well.
    Type: Application
    Filed: September 7, 2003
    Publication date: March 9, 2006
    Inventors: Andre Gorenflot, Eric Precigout, Stephane Delbecq, Theodorus Schetters